by Alexis DUPORT | 25 May, 2015 | Gènéthique informs you
A recent article published in the Science&Santé journal analyses the position of the European Union in terms of human embryo research. This article, which is supplemented by a more in-depth study in the Nature journal, provides an opportunity to readdress embryo...
by Alexis DUPORT | 6 May, 2015 | Gènéthique informs you
ESPERITE, the laboratory that markets the NIPS test, “tranquility”, announced that it “is ready for the mass market”. In a press release dated 30 April 2015, the laboratory confirmed that the test complies with European Directive 98/79/EC relating to medical devices...
by Alexis DUPORT | 14 Apr, 2015 | Gènéthique informs you
EllaOne® (ulipristal acetate) has been marketed in France since May 2009 by the HRA Pharma[1] laboratory. It is indicated in “emergency contraception within 120 hours (5 days) following unprotected sexual intercourse or if a contraceptive method fails”. ...
by Alexis DUPORT | 13 Apr, 2015 | Gènéthique informs you
In early April, a study on NIPS was published in The New England Journal of Medicine[1] (cf. Gènéthique du 7 avril 2015). These results were mostly welcomed by the media. However, the information conveyed confused “screening” with “diagnosis”. This confusion has...
by Alexis DUPORT | 31 Mar, 2015 | Gènéthique informs you
On 12 March 2015, “Toute une histoire” (the Full Story), a programme broadcast on France 2, broached the difficult subject of abortion “from a man’s perspective”. “My wife decided to have an abortion”. A “rather taboo...
by Alexis DUPORT | 30 Mar, 2015 | Gènéthique informs you
Whilst a motion for a resolution “on the European Union strategy for equality between men and women after 2015” is currently being worked on at the European Parliament, the GSEA (General Secretariat for European Affairs) – the Prime Minister’s...
